PACB

NASDAQStock

Pacific Biosciences of California, Inc.

$1.26-0.09 (-6.30%)

52-Week Range

$0.91

$2.67

Key Stats

Market Cap

380.5M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.30

Volume

5.3M

Avg Volume

6.0M

Performance

-29.83%

-40.09%

+5.83%

YTD

-30.98%

-0.78%

-85.45%

-96.40%

Price Chart

ETF Exposure

PACB is held by 54 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	148	$202	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	98	$133	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	74	$101	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	33	$44	$9.5M	0.12%

PreviousPage 2 of 2

About PACB ETF Exposure

Pacific Biosciences of California, Inc. (PACB) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 380.5M, PACB is a widely held institutional stock. The stock currently trades at $1.26. Investors can gain exposure to PACB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold PACB, sorted by portfolio weight.